ADVERTISEMENT

Black patients with ES-SCLC get less chemo but have better survival

Mark Fuerst L.   |   Medical News   |   30 November 2020
ADVERTISEMENT

FROM JTO CLINICAL AND RESEARCH REPORTS

Black patients with extensive-stage small cell lung cancer (ES-SCLC) are less likely to receive chemotherapy but have better survival, compared with White patients, according to a study published in JTO Clinical Research and Reports.

This study provides a large-scale analysis of real-world data identifying racial...

          

Topic Challenges

left
right